The 10 percent global import surcharge that President Trump imposed under Section 122 of the Trade Act of 1974 (19 U.S.C. § 2132) is scheduled to expire by operation of law at 12:01 a.m. EDT on July 24, 2026—150 days after it took effect on February 24. Section 122 caps a balance-of-payments surcharge at 150 days unless Congress affirmatively extends it, and no extension legislation is pending. Absent congressional action, the surcharge terminates on its own terms.
The surcharge's statutory expiration is distinct from the pending litigation over its legality. The Court of International Trade held the surcharge unlawful, and the Federal Circuit stayed that ruling pending the government's appeal in State of Oregon v. United States, so CBP has continued to collect the duty on entries through July 23. The July 24 sunset extinguishes the surcharge going forward but does not itself refund duties collected during the 150-day period; the disposition of amounts already paid remains tied to the appeal.
The expiration does not eliminate broader tariff exposure. The administration has advanced replacement measures on timelines that track the sunset. USTR's June 2, 2026 Section 301 determination concerning the forced-labor enforcement practices of 60 trading partners proposes additional duties of 10 to 12.5 percent, with a public hearing on July 7. Section 232 actions are proceeding in parallel, including 100 percent duties on patented pharmaceuticals and active pharmaceutical ingredients effective July 31 for larger companies and September 29 for others. Unlike Section 122, these authorities carry no statutory rate ceiling and no fixed expiration.
The Section 122 surcharge was in effect for the 150-day period beginning February 24, 2026, and terminates on July 24, 2026, absent congressional extension. The status of duties collected during that period remains subject to the pending appeal in State of Oregon v. United States.